Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia

J. Parigger; C. M. Zwaan; D. Reinhardt; G. J. L. Kaspers

doi:10.1586/14737140.2016.1129903

Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia

J. Parigger, C. M. Zwaan, D. Reinhardt, G. J. L. Kaspers

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	137-146
Journal	Expert Review of Anticancer Therapy
Volume	16
Issue number	2
DOIs	https://doi.org/10.1586/14737140.2016.1129903
Publication status	Published - 1 Feb 2016

Cite this

Parigger, J., Zwaan, C. M., Reinhardt, D., & Kaspers, G. J. L. (2016). Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia. Expert Review of Anticancer Therapy, 16(2), 137-146. https://doi.org/10.1586/14737140.2016.1129903

@article{19d448aeb5b04ec68f1096209d99aa0f,

title = "Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia",

keywords = "Gemtuzumab ozogamicin, toxicity, children, Mylotarg (R), efficacy, acute myeloid leukemia",

author = "J. Parigger and Zwaan, {C. M.} and D. Reinhardt and Kaspers, {G. J. L.}",

year = "2016",

month = "2",

day = "1",

doi = "10.1586/14737140.2016.1129903",

language = "English",

volume = "16",

pages = "137--146",

journal = "Expert Review of Anticancer Therapy",

issn = "1473-7140",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia

AU - Parigger, J.

AU - Zwaan, C. M.

AU - Reinhardt, D.

AU - Kaspers, G. J. L.

PY - 2016/2/1

Y1 - 2016/2/1

KW - Gemtuzumab ozogamicin

KW - toxicity

KW - children

KW - Mylotarg (R)

KW - efficacy

KW - acute myeloid leukemia

U2 - 10.1586/14737140.2016.1129903

DO - 10.1586/14737140.2016.1129903

M3 - Article

C2 - 26646091

VL - 16

SP - 137

EP - 146

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 2

ER -

Access to Document

10.1586/14737140.2016.1129903